A B S T R A C T The serum viscosity of diabetic patients has been found to be increased. The elevation averaged 8% above healthy subjects and 6% above nondiabetic patients. The serum viscosity elevation was greater when diabetic sequelae associated with microangiopathy were present. No relation of serum viscosity to age, sex, obesity, duration of disease, or type of treatment was demonstrated. Serum total protein and glucose levels were found to be correlated with serum viscosity, and increases in their serum concentrations were observed in diabetes. Analysis demonstrated that their elevation did not explain either the viscosity increase or the difference in viscosity between diabetics with and without sequelae.
More recently, Skovborg, Nielson, Schlichtkrull, and Ditzel (2), Labib et al. (3) , and Hoare, Beckett, and Dormandy (4) have demonstrated whole blood viscosity increase, and Isogai, Ichiba, Iida, Chikatsu, and Abe whole blood and plasma viscosity increase in diabetes (5) . Less conclusive studies suggesting blood viscosity disturbance have also been reported (6, 7) and studies describing a total lack of change (8, 9) or decrease (10) in plasma, serum, and blood viscosity have appeared.
Differing findings in diabetes are matched by disagreement about the relation of viscosity and diabetic sequelae. Serum viscosity elevation was reported to be similar in diabetes with and without retinopathy (1) but blood viscosity, normal in uncomplicated diabetes of short duration (11) , was reported to be increased in long-standing diabetes with retinopathy and associated with changes in serum electrophoretic pattern and fibrinogen levels (2, 11) .
Studies of serum viscosity changes in diabetes reported here demonstrate a well defined increase which is more pronounced when clinically evident microangiopathy is present. Additional analyses suggest that the increased viscosity is due to specific changes in serum composition.
METHODS
The study was done in three parts-individual serum viscosity measurements, determination of intrinsic viscosity ( [ 1] ) ' of large serum pools, and determination of [X] of fractions prepared using sodium sulfate on smaller serum pools.
Subject material. Serum for individual viscometry was obtained from 30 healthy subjects, 45 nondiabetic patients, and 45 diabetic patients after overnight fasting. An effort was made to match diabetic and nondiabetic subjects for age and sex. Replicate studies at least 1 wk apart were done on five healthy subjects and 19 diabetic patients. Healthy subjects had no family history of diabetes, were less than 20%o above ideal body weight (12) , and had no medical complaints. Nondiabetic patients had normal glucose tolerance during an evaluation for medical com-'Abbreziation used in this paper: [I] , intrinsic viscosity.
The Journal of Clinical Investigation Volume 53 April 1974 1071-1079 plaints. Glucose tolerance was considered normal if plasma glucose values were all below the following levels: fasting, 115; 1 h, 175; 2 h, 125; 3 h, 125 mg/dl. The nondiabetic patients received a wide-ranging array of diagnoses. Classified by system, there were 17 proctologic, 12 gastrointestinal, 11 dermatologic, 11 orthopedic, 11 cardiopulmonary, nine eye-ear-nose-throat, seven urologic, seven gynecologic, and six psychiatric diagnoses. Inflammatory disease of the urinary tract, bronchial tree, or skin was present in 16 subjects and peptic ulcer disease in four subjects. Malignancy was found in three subjects, two cutaneous and one colon carcinoma with extension. A family history of diabetes was given by 20 nondiabetic patients. Diabetic patients were also ambulatory, 36 had previously diagnosed diabetes and nine had just undergone glucose tolerance tests which were abnormal by the criteria of Wilkerson (13) . All established diabetics had received insulin, sulfonylureas, or biguanides, while none of the abnormal glucose tolerance subjects had received any treatment All diabetic subjects were examined for evidence of microangiopathic sequelae. Established diabetics had ophthalmoscopic examinations, were studied for age-adjusted vibration sense loss of the index finger and great toe by using a biothesiometer (14) , and had quantitative determinations of protein on 24-h urine specimens. Clearly recognizable microaneurysms, usually with exudates, were considered evidence of retinopathy. Diminution of vibration sense disproportionate to age was considered evidence of neutropathy. Proteinuria in excess of 300 mg daily was considered evidence of nephropathy.
The two pairs of serum pools used in the second part of the study were composed of equal amounts of previously frozen serum from overt diabetic or healthy subjects matched for age and sex. Some findings on the first pair of pools have already -been reported (15) . The second matched pools were from eight male and 12 female subjects; mean ages were diabetic, 41.1 yr; control, 41.7 yr.
The studies of part three were carried out on smaller pools of fresh serum from overt diabetic and healthy subjects. Both control pools and the first diabetic pool were from four subjects each, the second diabetic pool was from six subjects.
Viscosity studies. Studies of viscosity of individual sera (part one) were done using a Wells-Brookfield model LVT cone-plate viscometer (Brookfield Engineering Laboratories, Inc., Stoughton, Mass.) (16 Kragh (17) , including filtration of all samples through fine sintered glass. Two patterns of dilution were used. In the size 75 viscometer studies 1.0 ml of serum was placed in the viscometer initially with subsequent additions of 0.2, 0.3, 0.5, and 0.5 ml of 0.15 M sodium chloride solution (saline) producing solutions 5/6, 2/3, 1/2, and 2/5 the initial concentration. In the size 50 viscometer studies 2.0 ml of serum was used initially and 0.5, 0.5, 1.0, and 1.0 ml of saline were added sequentially to produce 4/5, 2/3, 1/2, and 2/5 the initial concentration.
Smaller serum pools were studied (part three) after salt fractionation was carried out by adding 150 ml of 23% sodium sulfate to 10 ml of pooled serum. Whole serum, supernate, and precipitate, the last redissolved by the addition of 15 ml of water, were then dialyzed against 0.15 M saline and the salt fractions concentrated to 5 ml or less with a Zeineh Microconcentrator (Biomed Instruments, Inc., Chicago, Ill.).
Other determinations. Serum protein concentrationswere measured by using the biuret reagent of Gornall, Bardawill, and David (18) . Serum glucose was determined by the Hoffman ferricyanide technique in the glucose tolerance studies and by the phenol-methyl salicylate-HSO4 (Hycel) technique in the established diabetics. The serum total solids content of capillary viscometry samples was determined by placing duplicate 1.0-ml aliquots in tared weighing bottles and drying them in vacuo over phosphorus pentoxide overnight and then for 2 h in vacuo at 106.5±1.50C before weighing. All values were corrected for sodium chloride content by subtracting 0.88 g/dl.
Radial immunodiffusion was used for measurements of individual serum proteins. Both plates and standards were obtained from Behring Diagnostics, Inc., Woodbury, N. Y. The same plate was used for duplicate studies of all four pools. The serum standard was used at three concentrations selected so that the sample concentrations fell within their range. The diameter (D) of all rings was measured, and sample concentration was determined graphically from a least squares plot of D2 for the three concentrations of the serum standard.
The electrophoretic analysis technique was designed to correct for increased stainability of albumin. Approximately 2 ul of serum was applied in a 1-cm band to 2.5-cm-wide cellulose acetate strips (Oxoid), and the proteins were migrated 60 min at 200 V in a Colab UnitizedTM electrophoresis tank (Colab Laboratories, Inc., Chicago Heights, Ill.). The wet strips were then stained by floating them on a 0.2% Ponceau S solution containing 3% trichloracetic acid, and destained by rinsing in 5% acetic acid. The uncleared globulin areas were scanned on a Photovolt Densicord scanner (Photovolt Corp., New York), using logarithmic compensation and a 595-nm filter. The albumin: globulin ratio was measured by eluting dye from appropriate strip segments. Cellulose acetate pieces of similar size from the same strip were also eluted as 'blanks. Elution with 3 ml 0.1% sodium hydroxide was followed by addition of 2 drops of glacial acetic acid to restore normal color. The absorbance at 525 nm and 610 nm was then measured on a Hitachi 139 spectrophotometer; the latter wavelength reading was used to correct for lightscattering elements eluted from strips.
Calculation of data. Serum viscosity values determined by cone-plate viscometry are reported directly in centipoise at 230 s7'. Capillary viscometry flow times were initially expressed as relative viscosity, 'Orel (19) , by using the following formula:
17rel= D X Tsample/Tsoivent where D is a factor to correct for increased sample density and Tsampie and Tsoi,..t the observed mean flow times for the sample and 0.15 M saline. The solvent time was adjusted to 47 dyn/cm surface tension.! The density factor was calculated by using the following formula: D= 1 +0.29 dp/(l + 0.71p) where d is the dilution, unity for the undiluted sample, and p is the protein concentration in g/ml. While using a partial specific volume reasonable for serum, the formula is essentially empiric; it was used because of its close relation to measured plasma densities (20) . [,7] was calculated *by using Kraemer's equation (19) The factor 0.62 was found by comparing albumin and globulin Ponceau S content in 24 pairs of strips with protein content determined by direct measurement of eluates of freshly separated fractions using the method of Lowry, Rosebrough, Farr, and Randall (25) . Then the adjusted albumin absorbance and the globulin absorbance were divided by their sum to determine the percentage of albumin and globulin present. The percentage in the al-, a2-, f,-, and y-globulin fractions was calculated by multiplying the globulin percentage by the proportion of each fraction in the total globulin of the scanned strip.
Statistical methods. Individual serum viscosity data were studied by using analysis of variance of four groups after replicate observations were averaged. The four groups were healthy subjects, nondiabetic patients, diabetics without sequelae, and diabetics with one or more of the three evaluated types of diabetic sequelae. The within groups mean square was used as the estimated variance in further t tests. Nested analysis of variance was used to derive the replicate observation (within subject) coefficient of variation; linear regression, correlation, and multiple covariance also followed standard techniques (22) .
RESULTS
Serum viscosity values, expressed as mean and standard deviation, are presented in Table I . The diabetic patients showed a significant elevation compared to both the healthy subjects and nondiabetic patients. The latter two group means did not differ significantly. When the Disturbance of Serum Viscosity in Diabetes MeUitus 1.14640.071 [22] 1.170±0.051 [20] 1.25740.088 [15] Age 50-59
1.182±0.044 [5] 1.192±-0.041 [13] 1.247±-0.093 [17] Age 60 or more 1.178±t0.028 [3] 1.165±0.045 [12] 1.245±-0.077 [13] Sex [7] 1.173±0.039 [19] 1.245±0.076 [19] Less than 20%
1.155±-0.065 [30] 1.165±0.039 [24] 1.24440.068 [13] Female 1.148±0.070 [23] 1.177±0.053 [26] 1.254±0.082 [26] More than 20% above ideal weight None 1.187i0.052 [21] 1.253±0.084 [32] Values are in centipoise at 37.0°C, given as mean±SD. The number of subjects in each grouip is shown in brackets. Age, sex, and obesity values were not statistically significantly different within groups, but significant differences remained when diabetic and nondiabetic patients were compared in each component diabetic patients were separated into those with and those without microangiopathic sequelae the group with sequelae had a higher mean value. The means differed by 4%. When the viscosity values were segregated by specific sequelae, the following mean values were found: retinopathy 1.280 cP [10] , neuropathy 1.277 cP [10] , and nephropathy 1.278 cP [9] . The excess of number of observations (in brackets) over total diabetics with sequelae is due to the presence of multiple sequelae in nine diabetics. Two other comparisons in the diabetic group based on duration and type of treatment showed no difference despite the fact that more patients with microangiopathic sequelae had long duration insulinrequiring diabetes. The short duration group was made somewhat lower by the presence of nine untreated, newly diagnosed, mild diabetics whose serum viscosity was 1.233±0.089 cP.
The effects of age, sex, and obesity on serum viscosity in the three groups are shown in Table II was nearly as large as the 6.3% group variation. The value of more than one study per subject was illustrated even more clearly when the 19 diabetic patients with replicate analyses were divided into nine without and ten with sequelae. A t test performed directly on their mean values showed statistical significance as high as for the entire group, t= 2.8, P < 0.02.
Adding sugar to any aqueous solution will raise its viscosity so that elevated levels of glucose could play a role in increasing serum viscosity in diabetes. Total serum protein levels also fluctuate and might affect serum viscosity. Serum glucose was measured in 43 diabetic and 45 nondiabetic patients, and total serum protein in 42 diabetics, 45 nondiabetic patients, and 24 healthy subjects. Both glucose and protein were measured in 40 diabetics. The serum viscosity and fasting glucose levels were positively correlated in the diabetics (r = + 0.30, P < 0.05) but not in nondiabetic patients (r = + 0.01). Serum viscosity and total protein were positively correlated in diabetic (r = + 0.36, P < 0.05) and nondiabetic patients (r = + 0.50, P < 0.001). The healthy control protein-viscosity correlation did not achieve statistical significance (r = + 0.27).
The effect of increased serum glucose and protein levels on serum viscosity has been assessed by using multiple analysis of covariance (Table III) . Mean serum protein levels were considerably higher in the Tables I and III. The serum protein composition of the two diabetic and two control pools was studied in detail. Mean values are given in Table IV . Electrophoretic analyses demonstrated a decrease in albumin: globulin ratio. Levels of individual globulins are also listed. The ratio of diabetic to normal level is given to help assess the degree of elevation. Four smaller serum pools were studied by using salt fractionation to determine whether differences between diabetic and control fractions could be detected. Dialyzed serum and two separated fractions were analyzed. Dialyzed diabetic serum [X] was higher than control serum [n] (Table V) , as was that of the supernatant fraction. Infranatant fraction values were quite similar. Electrophloretic studies demonstrated differing albumin percentages in the diabetic and control fractions. Simultaneous equations were used to calculate albumin and globulin [?7] values from the original observations; the derived [Xf] values, also shown in Table V , were similar in the diabetic and control pools.
DISCUSSION
The major finding of this study was an elevation of serum viscosity in diabetes related in degree to the presence or absence of clinically recognizable diabetic microangiopathy (Table I) . No effect of duration of diabetes on serum viscosity was observed despite the relation of both to diabetic microangiopathy. Insulin requirement had little or no relation to increased serum viscosity. Age, sex, and the presence of obesity were demonstrated to be unrelated to the observed changes (Table, III) . The serum viscosity level in diabetes was found to be correlated with serum protein and glucose levels but increased glucose and protein levels did not account for either the viscosity elevation in diabetes or the difference in serum viscosity between diabetics with or without microangiopathy (Table III) . Increased serum viscosity was directly related both to the diabetic state and to diabetic microangiopathy. Previously published studies have produced a less distinct picture. The elevation observed in this study is comparable to the increased serum viscosity observed by Cogan et al. (1) and the plasma viscosity increase reported by Isogai et al. (5) . Other studies have not demonstrated as large an increase (8) (9) (10) (11) . A possible explanation for this disagreement may be developed by integrating observations from this study with three previously reported phenomena. Serum viscosity has been shown to be correlated with serum protein level. An individual's serum protein level is affected by his recent posture and physical activity (26) . The increased protein level is the result of loss of plasma volume during standing and exercise. The plasma volume decreases more rapidly in diabetes in these circumstances (9) . In contrast to the elevated serum protein levels found in ambulatory outpatient diabetics in this study (Table III) , hospitalized diabetics have depressed serum protein levels (27) . The control subjects and diabetic and nondiabetic patients in this study came from their residence to the laboratory, usually by automobile. They had to walk from their cars to the laboratory and often sat several minutes before venesection. The recent activity of subjects studied has not been specified in past reports, but difference in recent physical activity forms a probable basis for much of the difference in observed viscosity levels.
Cogan et al. (1) The demonstration by statistical techniques that increased serum viscosity in diabetes is not due to increased glucose and protein levels (Table III) has been further corroborated by capillary viscometry on pooled diabetic and control serum (Fig. 1) . In the latter studies both total serum protein and total serum solids were measured (Table IV) . The difference between total serum solids and total protein is due principally to serum glucose and lipids, both of which are elevated in diabetes. If increased total protein, glucose, and lipid levels in diabetic serum cause the increased serum viscosity when diabetic serum is diluted to the same total solids concentration as control serum the viscosity should be the same. Not only is this untrue (Fig. 1) , but if one converts the inherent viscosity to serum viscosity in centipoise the proportion of the elevation of serum viscosity due to increased protein and nonprotein solids may be determined. When the diabetic pool content is reduced 0.27 g/dl to correct for increased protein content, serum viscosity falls from 1.250 cP to 1.224 cP. When the mean diabetic pool content is reduced 0.41 g/dl to correct for increased total solids, serum viscosity falls to 1.211 cP, compared with the mean control pool serum viscosity of 1.169 cP. Increased protein and nonprotein solids content accounted for less than half of the increased serum viscosity in diabetes. The major factor increasing serum viscosity in diabetes was an elevation of serum [n] . Serum (Table IV) . Albumin levels decreased while several globulins were present in higher concentrations. The four acute phase reactants measured, haptoglobin, a,-acid glycoprotein, a,-antitrypsin, and ceruloplasmin, were elevated more than 25% in diabetic serum. These proteins are called "acute phase reactants" because their levels increase after injury, surgery, and other types of stress or illness (30, 31 The observed increase in serum viscosity in diabetes is considerably less than that known to produce symptoms. In the hyperviscosity syndrome, serum viscosity is typically more than doubled (35, 37) . Despite this quanti,tative difference, the hyperviscosity syndronme shares some features with diabetic microangiopathic sequelae. Retinopathy occurs frequently, neurologic abnormalities are seen regularly, and proteinuria is often present (37) . While the conditions appear to differ in severity they also differ in rate of development. Changes too mild to produce symptoms might still gradually produce a disturbance of the microcirculation.
If increased serum or plasma viscosity is important in the pathogenesis of diabetic microangiopathy, an additional factor unique to diabetes might be required. Other chronic conditions are associated with changes in both viscosity (5) and serum protein composition (35) similar to those observed in diabetes. Elevated serum [X7] has been observed in rheumatic fever, tuberculosis, and carcinoma (31) . Since serum viscosity elevation in chronic disorders is probably not unique to diabetes, three possible explanations of the relation of increased serum viscosity to diabetic microangiopathy can be entertained. First, elevated serum viscosity may be due to an underlying metabolic disturbance which produces both serum protein changes and diabetic microangiopathy. Second, the duration of blood viscosity increase combined with its degree of elevation might be unique to diabetes so that in other chronic disorders not enough time elapses to produce a similar microangiopathy. Third, the elevated blood viscosity may combine with some circulation change unique to diabetes to generate microangiopathy. The proper choice between these three possibilities will depend on additional information.
